Skip to main content
Short courses & CPD
Biosciences

Antibody-Drug Conjugates 101

This course provides a comprehensive introduction to Antibody-Drug Conjugates (ADCs), exploring their development and role in targeted therapies. You gain an understanding of ADC production, including upstream and downstream processes, regardless of your scientific background.

 

Course overview

ADCs represent a revolutionary biopharmaceutical technology, combining the specificity of antibodies with the potency of small-molecule drugs. This course focuses on ADC manufacturing, clinical trial phases, and the unique characteristics of biologics and small molecules. Delivered by the National Horizons Centre (NHC), the course is for graduates and professionals looking to deepen their understanding of biopharma innovations.

Top five reasons to study this course:

  • Targeted therapy focus: learn about the cutting-edge field of ADCs and their application in targeted treatments.
  • Industry relevance: ADCs are rapidly evolving, offering promising career opportunities in biopharma.
  • Comprehensive learning: gain practical insights into upstream and downstream processing in ADC production.
  • Clinical trials knowledge: understand the phases of clinical development and their role in bringing ADCs to market.
  • Expert guidance: benefit from instruction by leading professionals in the biopharma field.

Download pdf

 

Course details

What you study

The course includes the following key modules:

Biologics vs. Small Molecules: understanding ADCs’ unique position between biologics and small molecules.

ADCs in Biopharma: explore the structure and application of ADCs in modern medicine.

Clinical Trial Phases: learn about the stages of clinical trials for ADCs.

Upstream and Downstream Processes: detailed breakdown of the ADC production pipeline, from cell line development to product purification.

How you learn

The course is delivered entirely online, providing you with the flexibility to complete it at your own pace, whenever and wherever it suits you. This allows you to balance the course with your current responsibilities, while still benefiting from expert guidance and access to a community of learners through discussion forums.

How you are assessed

This is a non-accredited course, meaning there are no formal assessments. You can focus on acquiring valuable knowledge without the added pressure of exams. The flexibility of the course allows you to revisit material, ensuring you thoroughly understand ADC production and clinical trial processes without worrying about grades or deadlines.

 

Entry requirements

Entry requirements

No prerequisites to entry for this course.

 

Employability

Career opportunities

Upon completion, learners can enter roles in biopharma, specifically in ADC research and development. The course also prepares you for roles in clinical trial management and bioprocessing.

 
 

Part-time

2024/25 entry

Fee for applicants:
£50

  • 100% online
  • Start date: TBC

Apply online

Enquire now

 

Get in touch

 
Go to top menu